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Controlled Clinical Evaluations
of Chlorine Dioxide, Chlorite
and Chlorate in Man
by Judith R. Lubbers,* Sudha Chauan,* and Joseph
R. Bianchine*
To assess the relative safety of chronically administered chlorine water disinfectants in man, a
controlled study was undertaken. The clinical evaluation was conducted in the three phases
common to investigational drug studies. Phase I, a rising does tolerance investigation, examined
the acute effects of progressively increasing single doses of chlorine disinfectants to normal
healthy adult male volunteers. Phase II considered the impact on normal subjects of daily
ingestion ofthe disinfectants at a concentration of5 mg/l. for twelve consecutive weeks. Persons
with a low level of glucose-6-phosphate dehydrogenase may be expected to be especially
susceptible to oxidative stress; therefore, in Phase III, chlorite at a concentration of5 mg/l. was
administered daily for twelve consecutive weeks to a small group of potentially at-risk
glucose-6-phosphate dehydrogenase-deficient subjects. Physiological impact was assessed by
evaluation of a battery of qualitative and quantitative tests. The three phases of this controlled
double-blind clinical evaluation of chlorine dioxide and its potential metabolites in human male
volunteer subjects were completed uneventfully. There were no obvious undesirable clinical
sequellae noted by any ofthe participating subjects or by the observing medical team. In several
cases, statistically significant trends in certain biochemical or physiological parameters were
associated with treatment; however, none of these trends was judged to have physiological
consequence. One cannot rule out the possibility that, over a longer treatment period, these
trends might indeed achieve proportions of clinical importance. However, by the absence of
detrimental physiological responses within the limits of the study, the relative safety of oral
ingestion of chlorine dioxide and its metabolites, chlorite and chlorate, was demonstrated.
Introduction
Chlorine dioxide is currently under serious con-
sideration in the United States as an alternative to
chlorine water treatment. Before chlorine dioxide
may be used routinely as a water disinfectant, the
safety of oral human ingestion of chlorine dioxide
and its by-products must be assessed. For this
purpose, a controlled clinical evaluation of chlorine
dioxide, chlorite and chlorate was undertaken under
the auspices of USEPA HERL #CR805643.
The study was conducted in three parts. Phase I
was designed to evaluate the acute physiological
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effects ofprogressively increasingdoses ofdisinfec-
tants administered to normal healthy adult males.
Chronic ingestion by normal male volunteers was
studied in Phase II. Phase III assessed the physio-
logical response of a small group of potentially
susceptible individuals, those deficient in glucose-6-
phosphate dehydrogenase, to chronic ingestion of
chlorite.
Methods
Subject Selection
For Phase I and for Phase II, normal healthy
adult male volunteers were selected. No prospec-
tive study participant who exhibited a significant
abnormality in the routine clinical serum analysis,58
blood count, urinalysis, or electrocardiogram was
selected. Subjects manifested no physical abnor-
malities at the pretreatment examination, were 21
to 35 years of age, and weighed within ± 10% of
normal body weight for their frame and stature. A
history of disease or any medical or surgical condi-
tion which might interfere with the absorption,
excretion, or metabolism ofsubstances by the body
precluded inclusion. Regular drug intake prior to
the start ofthe investigation, either therapeutic or
recreational, resulted in exclusion from the study.
Normalmethemoglobinlevels, thyroidfunction, and
glutathionelevelsweremandatory. Writteninformed
consent was obtained from each subject prior to
initiation of treatment.
ForPhase III, volunteers were defined as glucose-
6-phosphate dehydrogenase (G-6-PD)-deficient on
the basis ofa hemoglobin G-6-PD level ofless than
5.0 IU/GM hemoglobin in the pre-study screening.
PhaseIIIsubjectswerenormalinallotherrespects.
Water Disinfectant Preparation
A detailed description of the water disinfectant
preparation techniques has been presented by Lub-
bers and Bianchine (1). In general, freshly pre-
pared stock solutions of chlorine dioxide, sodium
chlorite, sodium chlorate, chlorine and chloramine
were assayed by the colorimetric techniques of
Palin (2) then diluted with organic-free demineral-
ized deionized water to appropriate concentrations.
Individual bottles were capped and stored in the
dark under refrigeration until use. All bottles were
coded by an independent observer and the identity
of each bottle remained "double-blind" to both the
investigative staff and the volunteer subjects.
Study Design: Phase I
The 60 volunteers in Phase I were divided at
random into six treatment groups (1). Ten persons
were assigned to receive each of the disinfectants;
the ten members of the control group received
untreated water. The study involved a series ofsix
sequences of three days each. Treatment concen-
trations were increased for each treatment. The
specific concentrations or disinfectant administered
to the study participants are listed in Table 1. A
clinical evaluation of the collection of blood and
urine samples for determination of pretreatment
baseline laboratory values preceded the first treat-
ment. On the first day ofeach three day treatment
sequence, each volunteer ingested 1000 ml of the
water in two portions. The second 500 ml portion
aliquot was administered 4 hr after the first. Each
500 ml portion was consumed within 15 min. Only
two doses ofdisinfectant were administered on the
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first day of each treatment sequence. No disinfec-
tant was administered on the second and third day
of each sequence, since these two days were to
serve as followup observation days. The second day
of the treatment sequence consisted of a physical
examination and collection of blood and urine sam-
ples for determination ofposttreatment laboratory
values. On the third day, each volunteer was given
aphysical examinationto determine residual effects
of treatment with the water disinfectants and
byproducts.
Taste evaluations were obtained at each dose
level. Study participants were asked to rate the
treated water as very unpleasant, slightly unpleas-
ant, not pleasant, pleasant, or tasteless.
Study Design: Phase II
The sixty volunteers ofPhase II were divided at
random into six treatment groups of ten subjects
each (3). In order to assure efficient management of
the 60 subjects, they were randomly assigned to
three subsets. These subsets were sequentially
entered into the study on three successive days and
exited fromthis studyin asimilarfashion. For all of
the treatment groups, the concentration of disin-
fectants ingested was 5 mg/l. The control group
received untreated water. Each subject received
500 ml daily for 12 weeks. Physicals, collection of
blood and urine samples for laboratory assays, and
taste evaluations were conducted on a weekly basis
duringthe treatment period and for8 weeks follow-
ing cessation of treatment.
Study Design: Phase III
The three glucose-6-phosphate dehydrogenase-
deficient subjects of Phase III were given sodium
chlorite at a concentration of 5 mg/I. chlorite (4).
The treatment protocol was identical to that of
Phase II, with daily administration of 500 ml of
solution to each volunteer.
Evaluation Procedures
An extensive battery of parameters was moni-
tored to assess the biochemical and physiological
response to the oral ingestion ofthe water disinfec-
tants and water treatment by-products (Table 2).
All laboratorydetermninations ofbiochemical param-
eters were conducted by a licensed medical labora-
tory, Consolidated Biomedical Laboratories, Inc.
(CBL), Columbus, Ohio, HEW license number
34-1030. Foreachvolunteer, pretreatmentbaseline
values and six sets of posttreatment values were
compiled. Laboratory tests were carefully chosen.ORAL INTAKE OF CHLORINE DISINFECTANTS IN MAN
Table 1. Concentration of disinfectants in phase I: acute rising dose tolerance.a
Disinfectant concentration, mg/l.
Water disinfectant Day 1 Day 4 Day 7 Day 10 Day 13 Day 16
Chlorate 0.01 0.1 0.5 1.0 1.8 2.4
Water control 0 0 0 0 0 0
Chlorine dioxide 0.1 1.0 5.0 10.0 18.0 24.0
Chlorite 0.01 0.1 0.5 1.0 1.8 2.4
Chlorine 0.1 1.0 5.0 10.0 18.0 24.0
Chloramine 0.01 1.0 8.0 18.0 24.0
aFor each dose, two portions of 500 ml each were administered at 4-hr intervals.
Table 2. Biochemical parameters assayed in the controlled clinical evaluation ofchlorine dioxide, chlorite and chlorate in man.
Serum chemistry
Blood count
Urinalysis
Special tests
Plasma glucose, sodium, potassium, chloride, urea nitrogen, creatinine, BUN/creatinine ratio, uric
acid, calcium, phosphorus, alkaline phosphatase, gammaglutamyltransferase, totalbilirubin, serum
glutamic-oxaloacetic transaminase, serum glutamic-pyruvic transaminase, lactic dehydrogenase,
cholesterol, triglycerides, total protein albumin, globulin, albumin/globulin ratio, iron
Platelet count, white blood cell count, red blood cell count, hemoglobin, hematocrit, mean
corpuscular volume, mean corpuscular volume, mean corpuscular hemoglobin, mean corpuscular
hemoglobin concentration, high peroxidase activity, neutrophils, lymphocytes, monocytes, eosino-
phils, basophils, large unstained cells
Color,a appearance,a specific gravity, pH, protein, sugar,a acetone, blood,a white blood count, red
blood count, casts,a crystals,a bacteria,a mucus*, amorphous cells,a epithelial cells
Serum haptoglobin, sickle cell,a methemoglobin, glucose-6-phosphate dehydrogenase, Coombs
test,a hemoglobin electrophoresis,a T-3 (uptake), T-4 (RIA), freethyroxine index, electrocardiograma
Physical exam Systolic blood pressure, diastolic blood pressure, respiration rate, pulse rate, oral temperature
aThese parameters yielded qualitative data only; no statistical analysis was performed.
On the basis of the literature (5-8), areas of sus-
pected biochemical response to ingestion ofchlorine
oxidants were defined; a portion ofthe test battery
was specifically devoted tomonitoringthis response.
Red blood cell surface antibody formation was clini-
cally monitored by the qualitative Coombs test;
thyroid function by T-3 (uptake), T-4 (RIA), and
free thyroxine; and response to oxidative stress by
glucose-6-phosphate dehydrogenase, methemoglobin
and glutathione levels. Hemoglobin electrophoresis
was used to detect possible hemoglobin abnormali-
ties. Abatteryofperipheralparameterswasassayed
to provide supplementary information and to assist
in evaluation of overall physiological well-being.
The specific serum, blood and urine parameters
assayed have been discussed by Lubbers and
Bianchine (1).
The numerical values obtained were collected
and analyzed by utilizing the facilities of The Ohio
State University Division of Computing Services
for Medical Education and Research. Specially
designed programs facilitated rapid clinical feed-
back. Any value for an individual subject which
differed from the group mean by more than two
standard deviations was noted. In addition, every
individual value which fell outside normal labora-
tory ranges for that parameter was designated as
abnormal. Chemical parameters for volunteers who
exhibited abnormal values were subjected to care-
ful scrutiny; the safety and the possibility ofhyper-
sensitivity to the disinfectant agents were evalu-
ated for each of these individuals on a continuing
basis throughout the study.
Statistical analyses utilized commercially avail-
able computer packages, specifically, the Biomedi-
cal ComputerPrograms (BMDP) and the Statistical
Package for the Social Sciences (SPSS). Two-way
analyses of variance with repeated measures uti-
lized BMDP2V. BMDP1R was used to perform
multiple linear regression analyses. For pairwise
t-testsandsimplet-tests, SPSS-T-testwasemployed.
Results
Qualitative
An important aspect ofthis study was the careful
and continued medical observation of all subjects.
The general clinical histories and physical examina-
tions alone with subjective observations and quali-
tative laboratory tests throughout this study were
accumulated in each subject's medical file. A careful
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inspection ofeach ofthese medical files presented a
review ofthe general clinical health ofeach subject.
The careful clinical evaluation ofevery subject in
Phases , II and III failed to reveal any clinically
important impact upon the medical well-being of
any subject as a result of disinfectant ingestion.
Further, there was no apparent grouping of the
minorsubjective symptoms and objective signs noted
throughout the study; the "colds," "lymphadeno-
pathy," "sore throats" and "flu" problems noted
episodically appearto berandomlydispersedamong
thetreatmentgroups. Allsubjectsremainednegative
with respect to the Coombs tests and the sickle cell
tests during the investigation. Hemoglobin electro-
phoresis results indicated that, in Phase II, a small
number of subjects yielded abnormal hemoglobin
distributions but these individuals were found to be
randomly distributed in both the treatment groups
and in the control group. Examination of electro-
cardiograms revealed no abnormalities.
Vital signs (blood pressure, pulse rate, respira-
tion rate and body temperature) were measured on
a regular basis to provide immediate feedback to
the monitoring physician on the acute physiological
response of study participants to treatment. The
statistical analysis ofthe vital signs was limited to
the calculation ofarithmetic group means and stan-
dard deviations from the mean. The compiled vital
signs were examined for evidence of consistent
responsetotreatment. Nosuchevidence wasfound.
The subjective evaluations of palatability indi-
cated that few subjects found the test substances to
have an objectionable taste at levels up to 24 mg/l.
Quantitative
Forthe Phase Iacuterising-dosetolerance study,
a two-way analysis ofvariance with repeated mea-
sures was used to compare the treatment group
values ofeach biochemical parameter to the corres-
pondingvalues ofthe control group. The analysis of
variance allowed distinctions to be made among the
possible sources of variation. Differences between
two groups that existed priorto treatment, parallel
variations in quantitative chemical values due to
laboratory drift and authentic treatment-related
changes in physiological parameters could be dis-
tinguished. Three probabilities were calculated for
each case: the group main effect (G), the time main
effect (R), and group-time interaction (RG). The
treatment groups and the corresponding biochemi-
cal parameters for which a strong probability of
treatment-related change was computed (that is,
RG
- 0.05) are listed in the first column ofTable 3.
To assist in determining the clinical importance
of the statistically significant group time interac-
tions, the group, mean and standard deviations
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from the mean were examined forthe pretreatment
baseline assay and each posttreatment assay for
each of the treatment groups. In all instances, the
group mean values remain well within the estab-
lished normal ranges.
On the basis of the small magnitude of change
within the normal range and the duration of the
study, it was concluded that the trends identified
by the analysis of variance are unlikely to be of
clinical importance. The possibility that the trends
might become clinically important with increased
exposure cannot be excluded.
Alternative statistical techniques were employed
for Phase II. An omnibus testing technique was
usedinitially. Totestthehypothesisthattheresponse
ofone ormore ofthe groups was different to that of
the rest ofthe groups, an analysis ofvariance with
repeated measures was performed in which values
for all six treatment groups were included. For the
parameters urea nitrogen and mean corpuscular
hemoglobin, RG-values < 0.05 were obtained. Sup-
plementary tests were performed. Analyses ofvari-
ance with repeated measures in which the values of
each treatment group were compared to the cor-
responding values of the control group were cho-
sen. The use of the analysis of variance in this
manner is flawed by the common control group.
However, the results of the analyses may be used
with caution. The analysis of variance yielded sta-
tistically significant RG-values in the comparison of
the group mean corpuscul ar hemoglobin values for
the chlorite and the chlorate groups and of the
group mean urea nitrogen values of chlorate and
chlorine dioxide treatment groups to the corres-
ponding control group values, as shown in Table 3.
No linear trends were detected by linear regres-
sion analysis of the chlorite group's mean corpus-
cular hemoglobin values, the chlorate group's urea
nitrogen levels orthe chlorite group's ureanitrogen
values.
Mean corpuscular hemoglobin levels in the chlo-
rate group yielded a probability of0.01 upon linear
regression analysis. The relative slope associated
withthechangeduringthe 12-weektreatmentperiod
was approximately 1% of the normal physiological
range per week. We believe that no physiological
importance may be attributed with confidence to
the variation. However, itisimpossible onthe basis
ofthis study to rule out the potential physiological
significance ofthe trend. Further study is warrant-
ed.
The small numberofsubjects (three) in Phase III
negated the value of many statistical procedures.
Linear regression analyses were chosen. The third
column ofTable 3 lists the biochemical parameters
for which a high probability ofchange with respect
to time was calculated. The p-values computed byORAL INTAKE OF CHLORINE DISINFECTANTS IN MAN
Table 3. Biochemical parameters and treatment groups in which statistical analyses indicated a high probability of change
which could be attributed to ingestion of disinfectant.
Test Phase Ia Phase l1b Phase ITIC
Urea nitrogen (BUN) Chlorite Chlorate
Chlorine dioxide
Creatinine Chlorite
Chlorine
BUN/creatinine Chlorite
Ratio
Uric acid Chlorine dioxide
Calcium Chlorine
Gamma glutamyl transferase Chlorine
Total bilirubin Chlorate
Albumin/globulin ratio Chlorite
Iron Chlorate
Methemoglobin Chlorate Chlorite
T-4 (RIA) Chlorite
Free thyroxine index Chlorite
Mean corpuscular hemoglobin Chlorite
Chlorate
Mean corpuscular hemoglobin concentration Chlorite
Lymphocytes Chlorine
aTwo-way analysis of variance yielded group-time interactions (RG values) S 0.05 in comparisons of treatment group values to
those of the control group.
bTwo-way analysis ofvariance yielded group-time interactions (RG-values) S 0.05 in both the omnibus and treatment group-control
group comparisons.
cLinear regression analysis indicated a strong probability of change with respect to time; p-values S 0.05.
the linear regression analysis were less than 0.05
for four biochemical parameters. To gauge the rela-
tive magnitude ofchange, the percent change ofthe
normal range per week was computed. These sta-
tistical analyses indicate a good probability that, for
A/G ratio, T-4 (RIA), free thyroxine, mean cor-
puscular hemoglobin concentration, and methemo-
globin values, a change with respect to time occurs
during the 12-week treatment period. However, in
the absence of a concurrent control group and tak-
ing into consideration the small group size and the
possibility of laboratory drift, one must exercise
caution in dealing with the results. We can say with
confidence only that trends were indicated. We
cannot say that these trends were of physiological
origin norcan we attribute physiological consequence
to them.
Discussion
Several researchers have addressed the physio-
logical effects of oral ingestion of the oxidizing
agents, chlorinedioxide, chlorite andchlorate. Musil
et al. (9) associated oral chlorite ingestion with
methemoglobin formation. In studies by Heffernan
et al. (7,8), Abdel-Rahman et al. (5) and Couri et al.
(6), hemolytic anemia and suppressed glutathione
levels were observed in animals treated with chlo-
rite. The oral administration of chlorate to labora-
tory animals has been shown to induce oxidative
destruction of hemoglobin and methemoglobin for-
mation (10, 11). The possibility of renal toxicity at
high levels of chlorite ingestion was suggested by
the increased kidney/body weight ratio reported by
Heffernan et al. (7). Haller and Northgraves (12)
and Fridlyand and Kagan (13) examined the chronic
toxicity oforally consumed chlorine dioxide in rats;
a slightly increased two-year mortality rate and a
decreased rate of weight gain were observed. Oral
administration ofchlorite (14-16) tomicewasshown
to increase mean corpuscular volume, osmotic fra-
gility, and glucose-6-phosphate dehydrogenase activ-
ity of erythrocytes; morphologic changes were
reported. In the African Green monkey, chlorine
dioxide adversely affected thyroid function; chlorite
ingestion yielded transient changes in hemoglobin
levels and red cell count (17). The maternal toxici-
ty, embryonic toxicity and the teratogenic potential
of concentrations of sodium chlorite was evaluated
in rats (18).
Unfortunately, the information available on the
impact of chlorine dioxide, chlorite, and chlorate
ingestion in man is severely limited. Epidemiologi-
cal studies (19,20) have failed to conclusively iden-
tify any significant exposure related effects. The
clinical evaluation described in this report was an
attempt to elucidate the effects of the chlorite,
chlorine dioxide and chlorate in man under con-
trolled clinical conditions.
During the course of the three-phase study, a
massive volume of raw data was acquired. Routine
urinalyses were performed and a meticulous exam-
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ination of this body of information was made. No
definitivefindingofdetrimentalphysiologicalimpact
was made in any ofthe three phases ofthis human
investigation ofthe relative safety and tolerance of
oralchlorinedisinfectantingestion. Inseveralcases,
statistically significant trends were associated with
treatment; however, none of these trends were
judgedtohaveimmediate physiological consequence.
One cannot rule out the possibility that, over a
longer treatment period, these trends might indeed
achieve proportions of clinical importance. Howev-
er, within the limits ofthe study, the relative safety
oforal ingestion ofchlorine dioxide and its metabo-
lites, chlorite and chlorate, was demonstrated by
the absence of detrimental physiological response.
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